Cargando…
Correction of Beta-Thalassemia IVS-II-654 Mutation in a Mouse Model Using Prime Editing
Prime editing was used to insert and correct various pathogenic mutations except for beta-thalassemia variants, which disrupt functional beta-globin and prevent hemoglobin assembly in erythrocytes. This study investigated the effect of gene correction using prime editor version 3 (PE3) in a mouse mo...
Autores principales: | Zhang, Haokun, Sun, Ruilin, Fei, Jian, Chen, Hongyan, Lu, Daru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180235/ https://www.ncbi.nlm.nih.gov/pubmed/35682629 http://dx.doi.org/10.3390/ijms23115948 |
Ejemplares similares
-
Prime Editor 3 Mediated Beta-Thalassemia Mutations of the HBB Gene in Human Erythroid Progenitor Cells
por: Zhang, Haokun, et al.
Publicado: (2022) -
Co-existence of myeloproliferative neoplasias and β-thalassemia with IVS-2-654 mutation—a case report
por: Wu, Cai, et al.
Publicado: (2020) -
Correction of RNA splicing defect in β(654)-thalassemia mice using CRISPR/Cas9 gene-editing technology
por: Lu, Dan, et al.
Publicado: (2021) -
Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs
por: Xu, Peng, et al.
Publicado: (2015) -
Multi-Omics Analysis in β-Thalassemia Using an HBB Gene-Knockout Human Erythroid Progenitor Cell Model
por: Zhou, Guoqiang, et al.
Publicado: (2022)